Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Taiwan
Clinical trial register · Taiwan

Clinical Trials in Taiwan

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2861 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2861
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 28 Kaohsiung City 19 Taichung 15 Taoyuan City 10 Changhua 4

Trials in this register

35 of 2861 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Sanofi
Phase 3
980
Changhua County, Chiayi City, Kaohsiung City, New Taipei City, Tainan, Taipei, Taoyuan City
2025-10-01
Recruiting
Sanofi
Phase 3
124
Kaohsiung City, Taipei, Taoyuan City
2025-09-26
Recruiting
Sanofi
Phase 4
35
Kaohsiung City, Taichung, Taipei
2025-09-23
Recruiting
Sanofi
Phase 4
218
Kaohsiung City, Taipei
2025-09-22
Recruiting
Sanofi
Phase 3
942
Changhua, Hsinchu, Kaohsiung City, Taichung, Taipei, Taoyuan City
2025-09-17
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Taipei
2025-04-01
Active, closed
Sanofi
Observational
79
Changhua, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan City
2024-11-11
Active, closed
Sanofi
Phase 2
556
Hualien City, Kaohsiung City, Taichung, Taipei, Taoyuan City
2024-11-07
By invitation
Sanofi
Phase 2
900
Taipei
2024-09-30
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Kaohsiung City, Taipei
2024-07-12
Recruiting
Sanofi
Phase 1
96
Changhua, Kaohsiung City, Taipei
2024-07-08
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
Sanofi
Phase 3
2,500
Hsinchu, Taipei
2024-04-16
Active, closed
Sanofi
Phase 2
999
Hsinchu, Kaohsiung City, New Taipei City, Taichung, Taipei, Taoyuan City
2023-04-03
Active, closed
Sanofi
Phase 2/3
1,856
Kaohsiung City, Taichung, Taipei, Taoyuan City
2022-08-22
Active, closed
Sanofi
Phase 3
531
Kaohsiung City, Tainan, Taipei
2022-06-23
Recruiting
Sanofi
Phase 3
284
Kaohsiung City, New Taipei City, Taipei, Taoyuan City
2022-02-15
Active, closed
Sanofi
Phase 4
1,339
Douliu, Kaohsiung City, Taichung, Taipei
2021-12-16
Active, closed
Sanofi
Phase 3
17
Taipei
2021-09-01
Active, closed
Sanofi
Observational
955
Kaohsiung City, Taichung, Taipei, Taoyuan County
2019-06-11
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-taiwan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,861 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Taiwan?

14 of the 35 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 35 studies
PhaseStudiesRecruitingShare
Phase 321960%
Phase 26117.1%
Phase 44311.4%
Observational205.7%
Phase 1112.9%
Phase 2/3102.9%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Sanofi3514

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Dermatitis Atopic (5) Asthma (3) Hemophilia (2) Plasma Cell Myeloma (2) Polyneuropathy, Inflammatory Demyelinating, Chronic (2) Hemophilia A (2) Chronic Obstructive Pulmonary Disease (2) Ulcerative Colitis (2) Crohn's Disease (2) Multiple Sclerosis (1) Immunoglobulin G4 Related Disease (1) Chronic Inflammatory Demyelinating Polyradiculoneuropathy (1) Colitis Ulcerative (1) Glycogen Storage Disease Type II (1) Fabry Disease (1)
→

Browse trials by site location

Taipei (28) Kaohsiung City (19) Taichung (15) Taoyuan City (10) Changhua (4) New Taipei City (4) Hsinchu (3) Changhua County (2) Chiayi City (2) Tainan (2) Taipei City (1) Taoyuan County (1) Douliu (1) Hualien City (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.